Involvement of sphingomyelinases in TNF signaling pathways

Chemistry and Physics of Lipids

Volumn 102, Issue 1-2, 1999, Pages 157-166

  Krönke, Martin ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Ceramide generation; Sphingomyelin; TNF induced activation

Indexed keywords

CERAMIDE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ENZYME ACTIVATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0345713145     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(99)00084-5     Document Type: Article

References (47)

1. Adam D., Wiegmann K., Adam-Klages S., Ruff A., Krönke M. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271:1996;14617-14622.
2. Adam D., Ruff A., Strelow A., Wiegmann K., Krönke M. Induction of stress-activated protein kinases/c-Jun N-terminal kinases by the p55 tumour necrosis factor receptor does not require sphingomyelinases. Biochem. J. 333:1998;343-350.
3. Adam-Klages S., Adam D., Wiegmann K., Struve S., Kolanus W., Schneider-Mergener J., Krönke M. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 86:1996;937-947.
4. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
5. Chinnaiyan A.M., Tepper C.G., Seldin M.F., O'Rourke K., Kischkel F.C., Hellbardt S., Krammer P.H., Peter M.E., Dixit V.M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
6. Deiss L.P., Galinka H., Berissi H., Cohen O., Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15:1996;3861-3870.
7. Ellis H.M., Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:1986;817-829.
8. Gamard C.J., Dbaibo G.S., Liu B., Obeid L.M., Hannun Y.A. Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappaB. J. Biol. Chem. 272:1997;16474-16481.
9. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science. 274:1996;1855-1859.
10. Horinouchi K., Erlich S., Perl D.P., Ferlinz K., Bisgaier C.L., Sandhoff K., Desnick R.J., Stewart C.L., Schuchman E.H. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Genet. 10:1995;288-293.
11. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
12. Huwiler A., Brunner J., Hummel R., Vervoordeldonk M., Stabel S., van B.-H., Pfeilschifter J. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA. 93:1996;6959-6963.
13. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 8:1998;297-303.
14. Kolesnick R.N., Krönke M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60:1998;643-665.
15. Kreder, D., Adam-Klages, S., Wiegmann, K., Scherer, G., Plitz, T., Jensen, J.M., Proksch, E., Steinmann, J., Pfeffer, K., Krönke, M., 1998. Chediak-Higashi-like syndrome in FAN-deficient mice (submitted for publication).
16. Krönke M. The mode of ceramide action: the alkyl chain protrusion model. Cytokine Growth Factor Rev. 8:1997;103-107.
17. Kuno K., Sukegawa K., Ishikawa Y., Orii T., Matsushima K. Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NFκB activation. Int. Immunol. 6:1994;1269-1272.
18. Liu P., Anderson R.G. Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270:1995;27179-27185.
19. Lozano J., Berra E., Municio M.M., Diaz Meco M.T., Dominguez I., Sanz L., Moscat J. Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269:1994;19200-19202.
20. Mathias S., Dressler K.A., Kolesnick R.N. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor α Proc. Natl. Acad. Sci. USA. 88:1991;10009-10013.
21. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827.
22. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
23. Neer E.J., Schmidt C.J., Nambudripad R., Smith T.F. The ancient regulatory-protein family of WD-repeat proteinsin. Nature. 371:1994;297-300.
24. Otterbach B., Stoffel W. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell. 81:1995;1053-1061.
25. Pushkareva M., Obeid L.M., Hannun Y.A. Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol. Today. 16:1995;294-297.
26. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science. 262:1993;695-700.
27. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269:1995;1424-1427.
28. Santana P., Pena L.A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon Cardo C., Schuchman E.H., Fuks Z., Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86:1996;189-199.
29. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem. 271:1996;18431-18436.
30. Schissel S.L., Keesler G.A., Schuchman E.H., Williams K.J., Tabas I. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J. Biol. Chem. 273:1998;18250-18259.
31. Schuchman E.H., Suchi M., Takahashi T., Sandhoff K., Desnick R.J. Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J. Biol. Chem. 266:1991;8531-8539.
32. Schütze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Krönke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell. 71:1992;765-776.
33. Schütze, S., Machleidt, T., Adam, D., Schwandner, R., Wiegmann, K., Kruse, M.-L., Heinrich, M., Wickel, M., Krönke, M., 1998. Inhibition of receptor internalization by monodansyl cadaverine selectively blocks p55 TNF receptor death domain signaling (submitted for publication).
34. Schwandner R., Wiegmann K., Bernardo K., Kreder D., Krönke M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273:1998;5916-5922.
35. Smyth M.J., Perry D.K., Zhang J., Poirier G.G., Hannun Y.A., Obeid L.M. PRICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem. J. 316:1996;25-28.
36. Spiegel S., Merrill A.H. Jr. Sphingolipid metabolism and cell growth regulation. FASEB J. 10:1996;1388-1397.
37. Tomiuk S., Hofmann K., Nix M., Zumbansen M., Stoffel W. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl. Acad. Sci. USA. 95:1998;3638-3643.
38. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380:1996;75-79.
39. Wallach D. Cell death induction by TNF: a matter of self control. TIBS. 22:1997;107-109.
40. Wiegmann K., Schütze S., Machleidt T., Witte D., Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1994;1005-1015.
41. Wiegmann, K., Schwandner, R., Krut, O., Yeh, W.-G., Mak, T.W., Krönke, M., 1999. Required of FADD for Tumor Necrosis Factor-induced activation of acid schingomyelinase. J. Biol. Chem. 274, 5267-5370.
42. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endonuclease activation. Nature. 284:1997;554-556.
43. Yang Z., Costanzo M., Golde D.W., Kolesnick R.N. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J. Biol. Chem. 268:1993;20520-20523.
44. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., Mak T.W. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.
45. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:1993;641-652.
46. Zhang J., Alter N., Reed J.C., Borner C., Obeid L.M., Hannun Y.A. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. USA. 93:1996;5325-5328.
47. Zhang Y., Yao B., Delikat S., Bayoumy S., Lin X.H., McGinley M., Chan-Hui P.-Y., Lichenstein H., Kolesnick R. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell. 89:1997;63-72.